The percentage of cancer cells in early apoptosis was significantly increased after the treatment with a combination of Polθi and PARPi or RAD52i, Polθi and TMZ, and the three compounds together in comparison to the control and separate inhibition of Polθ. The gene discussed is ENSG00000223804; the disease is cancer.